Investigating the relationship between mammographic breast density and triple negative breast cancer in Nova Scotia, Canada
Abstract
The study objectives were to estimate the association between mammographic breast density (MBD) and triple negative breast cancers (TNBC); as well as to estimate the discriminatory ability of MBD, alone and with clinical risk factors, in the screening population. This case-control study consisted of 121 TNBC cases with a full-field digital mammography (FFDM) screen in 2009-2015 in Nova Scotia. The 6807 controls were women with a prior negative FFDM screening mammogram episode. Odds ratios and areas under curves were reported for models generated using two measures of MBD, percent and BI-RADS categories (5th ed.), both separately and in combination. Aside from the two forms of MBD, other variables included self-reported risk factors (menopausal status, hormone replacement therapy use, parity, family history), biopsy history, and derived breast volume. A significant positive association was found between MBD and TNBC in this screening population. The addition of clinical factors to density improved the discriminatory ability of the prediction models.
Collections
Related items
Showing items related by title, author, creator and subject.
-
Development of reports containing health indicators generated with data extracted from cancer data management software
Wills, James (2012-05-24)This report describes the Master of Health Informatics internship undertaken by James Wills at the Nova Scotia Breast Screening Program (NSBSP) in 2011. NSBSP is mandated to provide early detection of breast cancer through ... -
DEFINING THE MECHANISMS THROUGH WHICH ALDH1A3-INDUCED LONG NONCODING RNA NRAD1 REGULATES GENE EXPRESSION IN BREAST CANCER
Brown, Justin (2021-08-20)Triple-negative breast cancer (TNBC) is an aggressive subtype with limited treatment options and poor patient prognoses, owing partially to its enrichment in cancer stem cells (CSCs). Therapies targeting CSCs within TNBCs, ... -
Characterizing metformin response and sensitivity biomarkers in breast cancer
Anthes, Livia Esther (2018-09-28)The anti-diabetic drug metformin has been shown to exhibit broad in vitro and in vivo anti-neoplastic activity in various cancer types, including breast cancer. Despite numerous clinical trials ongoing, no targeted biomarkers ...